Selection bias in rheumatic disease research

scientific article

Selection bias in rheumatic disease research is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1008858019
P356DOI10.1038/NRRHEUM.2014.36
P8608Fatcat IDrelease_2cyyvfibhvdlppu4cvda55y2pi
P932PMC publication ID4260806
P698PubMed publication ID24686510

P50authorUyen-Sa NguyenQ40879800
Yuqing ZhangQ43157198
Goodarz DanaeiQ70954653
P2093author name stringJingbo Niu
Hyon K Choi
P2860cites workPrediction of Coronary Heart Disease Using Risk Factor CategoriesQ22241923
Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritisQ26822912
The "smoker's paradox" in patients with acute coronary syndrome: a systematic reviewQ27007476
The prevention and treatment of missing data in clinical trialsQ30571921
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsQ33243658
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisQ33505914
Osteoarthritis: new insights. Part 1: the disease and its risk factors.Q33921631
Index event bias as an explanation for the paradoxes of recurrence risk researchQ33972231
Estrogen plus progestin and the risk of coronary heart diseaseQ34220432
Methodologic challenges in studying risk factors for progression of knee osteoarthritisQ34222381
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from SwedenQ34236174
Hormone therapy to prevent disease and prolong life in postmenopausal womenQ34262585
Smoking and risk of incident psoriatic arthritis in US womenQ34266162
What effect is really being measured? An alternative explanation of paradoxical phenomena in studies of osteoarthritis progressionQ34383621
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studiesQ34558916
The table 2 fallacy: presenting and interpreting confounder and modifier coefficientsQ34570540
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarctionQ34633720
Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effectQ34663972
Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseQ34684331
The prevalence and burden of arthritisQ34781956
Heart disease and rheumatoid arthritis: understanding the risksQ35019085
Conditioning on intermediates in perinatal epidemiologyQ35619321
Body composition and coronary heart disease mortality--an obesity or a lean paradox?Q35671806
The genetics of psoriasis, psoriatic arthritis and atopic dermatitisQ35680691
Cigarette smoking and radiographic progression in rheumatoid arthritisQ35953570
Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseasesQ36191250
Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studiesQ36723733
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyQ36757060
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.Q36837333
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart diseaseQ37063519
Genetics of psoriasis and psoriatic arthritis: update and future direction.Q37210204
Randomized trials analyzed as observational studiesQ37387434
Methodological considerations, such as directed acyclic graphs, for studying "acute on chronic" disease epidemiology: chronic obstructive pulmonary disease example.Q37390981
Is Patent Foramen Ovale a Modifiable Risk Factor for Stroke Recurrence?Q37793687
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Q37883018
Risk factors for the incidence and progression of radiographic knee osteoarthritisQ39119596
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal womenQ40379806
Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macrosQ40866280
Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trialQ41917264
Therapies for active rheumatoid arthritis after methotrexate failureQ41925478
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medicationsQ41930813
Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasisQ41932479
Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohortQ42608056
Prior aspirin use and outcomes in acute coronary syndromesQ42858855
Body mass index and mortality: comment on article by Wolfe and MichaudQ42920607
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.Q43488992
Mortality of British doctors in relation to smoking: observations on coronary thrombosisQ43810965
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetesQ45040932
Effect of body mass index on mortality and clinical status in rheumatoid arthritisQ45158519
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?Q45235877
Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian womenQ46261361
The birth weight "paradox" uncovered?Q46341172
The obesity paradox and weight lossQ47363857
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study.Q50959252
Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?Q51033276
Invited commentary: when bad genes look good - APOE*E4, cognitive decline, and diagnostic thresholds.Q51917429
Epidemiology of osteoarthritis.Q53134775
Is Anti-TNF Therapy Safer Than Previously Thought?Q56969676
The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritisQ57751492
Index event bias—a numerical exampleQ58832125
A prospective study of obesity and risk of coronary heart disease in womenQ68730490
Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham StudyQ73715425
The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford StudyQ77567471
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammationQ80932706
Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic stateQ84959717
The association between smoking and the development of psoriatic arthritis among psoriasis patientsQ85001924
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectrheumatismQ684924
biasQ742736
P304page(s)403-412
P577publication date2014-04-01
P1433published inNature Reviews RheumatologyQ2107227
P1476titleSelection bias in rheumatic disease research
P478volume10

Reverse relations

cites work (P2860)
Q38387733Active-comparator design and new-user design in observational studies
Q58609925Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis
Q92464675Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment
Q42275944Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis
Q31106348Dietary Fat Intake and Radiographic Progression of Knee Osteoarthritis: Data From the Osteoarthritis Initiative
Q34604608Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases
Q37531008Improved survival in rheumatoid arthritis: a general population-based cohort study
Q36254129Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
Q52312175Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.
Q37601459Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis
Q37603973Intermittent Nitrate Use and Risk of Hip Fracture
Q40688085Obesity Paradox in Recurrent Attacks of Gout in Observational Studies: Clarification and Remedy
Q38887484Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain
Q90426314Patterns of Change Over Time in Knee Bone Shape Are Associated with Sex
Q38655838Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology
Q33898530Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
Q41117390Prevalence of knee osteoarthritis, risk factors, and quality of life: The Fifth Korean National Health And Nutrition Examination Survey
Q40073352Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.
Q38775863Quantifying the extent to which index event biases influence large genetic association studies
Q38764974Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.
Q99556760Risk of venous thromboembolism in knee, hip and hand osteoarthritis: a general population-based cohort study
Q47658094Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.
Q47110507Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
Q35092457The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Q58785132Towards secondary prevention of early knee osteoarthritis
Q35416463Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival
Q50092295Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).

Search more.